Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Clinical trial NCT02976675 · UNKNOWN
Trial details
- NCT number
- NCT02976675
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-06-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.